Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-16
1987-05-26
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514444, 514445, 514447, 514448, 549 54, 549 55, A61K 3138, C07D33362
Patent
active
046686975
ABSTRACT:
Novel 2-sulfamoylbenzo[b]thiophenes and derivatives thereof are shown to be useful for the treatment of elevated intraocular pressure in compositions including ophthalmic drops and inserts.
REFERENCES:
patent: 3428655 (1969-02-01), Milton et al.
patent: 3639613 (1972-02-01), Dunn et al.
patent: 4298613 (1980-05-01), Lepone
patent: 4386098 (1983-05-01), Woltersdorf, Jr. et al.
patent: 4426388 (1984-01-01), Woltersdorf, Jr.
patent: 4472417 (1984-09-01), Woltersdorf, Jr.
patent: 4472418 (1984-09-01), Woltersdorf, Jr.
patent: 4477466 (1984-10-01), Shepard
patent: 4500538 (1985-02-01), Woltersdorf
Hampel et al, "Glossary of Chemical Terms", Van Nostrand Reinhold Co., N.Y., 1976, p. 207.
Graham Samuel L.
Shepard Kenneth L.
Ford John M.
Merck & Co. , Inc.
Mullins J. G.
Nicholson William H.
Sudol Michael C.
LandOfFree
Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sul does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sul, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sul will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-704132